Product Code: ETC6185819 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The NGS services market in Australia is expanding rapidly, with a growing demand for sequencing services from hospitals, research centers, and clinical laboratories. As personalized medicine gains traction, the demand for whole-genome sequencing, targeted gene sequencing, and other NGS-based tests is increasing. Australian service providers are offering various sequencing services to meet the needs of healthcare professionals and researchers. These services play a pivotal role in the early detection of diseases, monitoring of treatment efficacy, and guiding clinical decision-making. The market`s growth is further supported by the advancement of bioinformatics tools that facilitate the analysis and interpretation of NGS data.
Australia`s NGS services market is expanding rapidly as more healthcare providers and research organizations recognize the value of outsourcing genomic sequencing and analysis. The trend is driven by the increasing need for expert services in NGS analysis due to the complexity and scale of genomic data. Key developments include the rise of cloud-based genomic services, which enable seamless data storage, analysis, and collaboration across institutions. Furthermore, the increasing focus on population genomics and the development of large-scale genomic databases in Australia is accelerating demand for NGS services. The market is also witnessing an increase in partnerships between private and public sectors to expand access to advanced NGS services for clinical and research purposes.
In the Australia NGS services market, one of the main challenges is the high operational cost associated with the implementation of sequencing services. This includes the expensive equipment, reagents, and ongoing maintenance costs. Additionally, data analysis and interpretation remain major obstacles, as processing large datasets often requires sophisticated tools and highly skilled personnel. Another challenge is the need for effective collaboration between clinicians, researchers, and bioinformaticians to ensure the clinical applicability of NGS data, particularly in personalized medicine. The availability of reimbursement for NGS services also remains inconsistent, which can limit the accessibility of these services for patients.
Australias NGS services market is witnessing a surge in demand as more healthcare institutions adopt genomic testing for diagnostics and treatment planning. This sector offers significant investment opportunities in contract research organizations (CROs), biotechnology firms, and diagnostic laboratories offering NGS services. As precision medicine gains momentum, the need for specialized services that can interpret and analyze genomic data is expanding. Investors can capitalize on opportunities in services such as genetic testing, biomarker discovery, and drug development research. The growing adoption of NGS services for oncology and rare diseases further strengthens the investment landscape in this market.
Government policies related to the NGS services market in Australia focus on increasing access to high-quality genetic testing services for the public. Initiatives such as Medicare reimbursement for certain genetic testing procedures ensure that a broader range of patients can benefit from NGS services. The Australian Government has also supported large-scale genomic initiatives like the Genomics Health Futures Mission, which aims to improve the integration of genomic information into healthcare systems, fostering further growth in the NGS services sector.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia NGS Services Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia NGS Services Market Revenues & Volume, 2021 & 2031F |
3.3 Australia NGS Services Market - Industry Life Cycle |
3.4 Australia NGS Services Market - Porter's Five Forces |
3.5 Australia NGS Services Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Australia NGS Services Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Australia NGS Services Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.8 Australia NGS Services Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia NGS Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia NGS Services Market Trends |
6 Australia NGS Services Market, By Types |
6.1 Australia NGS Services Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Australia NGS Services Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Australia NGS Services Market Revenues & Volume, By SBS, 2021- 2031F |
6.1.4 Australia NGS Services Market Revenues & Volume, By Ion Semiconductor, 2021- 2031F |
6.1.5 Australia NGS Services Market Revenues & Volume, By SBL, 2021- 2031F |
6.1.6 Australia NGS Services Market Revenues & Volume, By Pyro-Sequencing, 2021- 2031F |
6.1.7 Australia NGS Services Market Revenues & Volume, By SMRT, 2021- 2031F |
6.2 Australia NGS Services Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia NGS Services Market Revenues & Volume, By Research applications, 2021- 2031F |
6.2.3 Australia NGS Services Market Revenues & Volume, By Clinical applications, 2021- 2031F |
6.2.4 Australia NGS Services Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.2.5 Australia NGS Services Market Revenues & Volume, By RNA-sequencing, 2021- 2031F |
6.2.6 Australia NGS Services Market Revenues & Volume, By Targeted sequencing, 2021- 2031F |
6.2.7 Australia NGS Services Market Revenues & Volume, By Exome sequencing, 2021- 2031F |
6.2.8 Australia NGS Services Market Revenues & Volume, By Other, 2021- 2031F |
6.2.9 Australia NGS Services Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Australia NGS Services Market, By Disease Type |
6.3.1 Overview and Analysis |
6.3.2 Australia NGS Services Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.3 Australia NGS Services Market Revenues & Volume, By Lung cancer, 2021- 2031F |
6.3.4 Australia NGS Services Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.3.5 Australia NGS Services Market Revenues & Volume, By Prostate cancer, 2021- 2031F |
6.3.6 Australia NGS Services Market Revenues & Volume, By Colorectal cancer, 2021- 2031F |
6.3.7 Australia NGS Services Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Australia NGS Services Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Australia NGS Services Market Revenues & Volume, By Research centres, academic & government institutes, 2021- 2031F |
6.4.3 Australia NGS Services Market Revenues & Volume, By Hospitals & clinics, 2021- 2031F |
6.4.4 Australia NGS Services Market Revenues & Volume, By Pharmaceutical & biotechnology companies, 2021- 2031F |
6.4.5 Australia NGS Services Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia NGS Services Market Import-Export Trade Statistics |
7.1 Australia NGS Services Market Export to Major Countries |
7.2 Australia NGS Services Market Imports from Major Countries |
8 Australia NGS Services Market Key Performance Indicators |
9 Australia NGS Services Market - Opportunity Assessment |
9.1 Australia NGS Services Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Australia NGS Services Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Australia NGS Services Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.4 Australia NGS Services Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia NGS Services Market - Competitive Landscape |
10.1 Australia NGS Services Market Revenue Share, By Companies, 2024 |
10.2 Australia NGS Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |